Screener
BridgeBio Pharma BBIO Operating Lease Liability Payments Due
Operating Lease Liability Payments Due at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.
The source filing: BridgeBio Pharma’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001743881-26-000027
FAQ
- What is BridgeBio Pharma's operating lease liability payments due?
- BridgeBio Pharma (BBIO) reported operating lease liability payments due of $22.96M in Q2 2026.
- What does operating lease liability payments due mean?
- This represents the total future cash outflows required to satisfy operating lease agreements. It reflects the company's reliance on leased assets rather than owned assets to conduct business operations. Monitoring this helps evaluate the company's operational leverage and fixed cost structure.
Ask your AI about BridgeBio Pharma's operating lease liability payments due.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude